The history of intervention trials of periconception folic acid with multivitamin and folic acid supplementation in women has shown a recent breakthrough in the primary prevention of structural birth defects, namely neural-tube defects and some other congenital abnormalities. Recently, some studies have demonstrated the efficacy of this new method in reducing congenital abnormalities with specific origin; for example, in the offspring of diabetic and epileptic mothers, and in pregnancy with high fever. The benefits and drawbacks of four possible uses of periconception folate/folic acid and multivitamin supplementation are discussed: we believe there has been a missed opportunity to implement this preventive approach in medical practice. The four methods are as follows: (i) dietary intake of folate and other vitamins, (ii) periconception folic acid/multivitamin supplementation, (iii) food fortification with folic acid, and (iv) the combination of oral contraceptives with 6S-5-methytetrahydrofolate ('folate').Keywords: cardiovascular malformations, contraception, folic acid, multivitamins, neural-tube defects, prevention
Historical backgroundThe occurrence of neural-tube defects (NTDs) depends on maternal socio-economic status (i.e. low risk in the highest social class to an aboveaverage risk in the lowest class) [Elwood et al. 1992]. Thus, Smithells and colleagues hypothesized that undernutrition could be the common factor in the origin of NTDs [Smithells et al. 1976]. As a result, the same group tested the effect of diet supplemented with a multivitamin containing 0.36 mg folic acid in the first intervention trial [Smithells et al. 1980]. Women who had given birth to one or more previous infants with NTDs were supplemented with this multivitamin during the periconception period while controls were recruited among similar women who were already pregnant without vitamin supplementation. The results of Smithells et al.'s study were published separately for the Yorkshire region of the UK [Smithells et al. 1989] and Northern Ireland [Nevin and Seller, 1990], and they reported a 91% and 83% reduction in NTD recurrence for the two areas, respectively.However, their results were not accepted by some experts due to possible selection bias in their nonrandomized controlled trial (non-RCT). Thus, the Medical Research Council (MRC) in the UK [MRC Vitamin Study Research Group, 1991] organized a multicenter RCT (43% of participants came from Hungary). There were four supplementation groups: folic acid (4 mg), other vitamins, folic acid and other vitamins, and minerals as a control. The results of the MRC Vitamin Study showed that a pharmacological dose of folic acid 4 mg can reduce NTD recurrence by 71% compared with minerals (0.8% versus 4.3%; relative risk [RR] 0.29 with 95% confidence interval [CI] 0.120.71). Other vitamins were not associated with a significant reduction of NTD recurrence.